UK

Upender Kumar

Active Director Director DIN 08152507
DIN 08152507 First appointment Jun 2018 Primary industry Business Services
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 2 active board seats
Total affiliations 2 Since Jun 2018
Shareholding value β€’β€’β€’β€’ Premium profile

About Upender Kumar

Data last updated:

Upender Kumar is a Director at Zoritor Herbs & Pharma Private Limited (since 2018) and Director at Moleque International Private Limited (since 2018). The companies operate in Business Services and Electrnoics.

DIN 08152507
Primary Designation Director
Industry Business Services
First Appointment 07 Jun 2018
Oldest Company Age 8 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director21 Jun 20182018Active
Director07 Jun 20182018Active

Directorship timeline

Open interactive timeline →
Moleque International Private Limited
Zoritor Herbs & Pharma Private Limited
Premium access

Shareholding and investment profile for Upender Kumar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Upender Kumar

Upender Kumar currently holds 2 directorships: Zoritor Herbs & Pharma Private Limited (Director, since 21 Jun 2018); Moleque International Private Limited (Director, since 07 Jun 2018).

Upender Kumar was first appointed on 07 Jun 2018 as Director at Moleque International Private Limited.

The current boards of Upender Kumar's companies include Pawan Kumar Net Ram Soni (Zoritor Herbs & Pharma Private Limited), Vikash Kumar (Zoritor Herbs & Pharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available